Santé Cie Acquires APOSAN from IK Investment Partners
July 27, 2020
Santé Cie Group, a French home medical assistance platform majority-owned by Ardian, has agreed to acquire a majority stake in German pharmaceutical homecare provider APOSAN from the IK Small Cap I Fund (advised by IK Investment Partners). The deal advances Santé Cie's internationalisation into Germany and expands its outpatient therapy and pharmaceutical compounding capabilities; the combined group will serve more patients across France and Germany and is expected to create a joint business with >€300m revenue and 1,850+ employees once closed (subject to antitrust approval).
- Buyers
- Santé Cie Group, Ardian
- Targets
- APOSAN
- Sellers
- IK Small Cap I Fund (advised by IK Investment Partners)
- Platforms
- Santé Cie Group
- Industry
- Healthcare Services
- Location
- North Rhine-Westphalia, Germany
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Vivalto Partners Leads Consortium to Acquire Vivalto Santé
November 30, 2021
Healthcare Services
Vivalto Partners has closed the acquisition of Vivalto Santé, the third-largest private hospitals group in France, bringing together 50 facilities, over 10,000 employees and more than €1 billion in annual revenue. The deal is backed by historical institutional investors (MACSF, Arkéa Capital, BNP Paribas Développement, Groupe Crédit Agricole, Mubadala and Bpifrance) and welcomes new partners IK Partners and Hayfin to support the group's next phase of growth and expanded employee/practitioner shareholding.
-
IK Partners Leads Investment in Sofia Développement
February 23, 2022
Software
IK Partners’ IK Small Cap III Fund has agreed to invest in French e‑health software provider Sofia Développement, joining existing shareholders Extens, Capital Croissance and Bpifrance. The capital will finance accelerated organic growth, product expansion toward a fully integrated digital practice management solution and future acquisitions; management will reinvest alongside the investors.
-
Equistone Partners Europe Acquires Majority Stake in Omnicare
August 14, 2019
Pharmaceuticals
Equistone Partners Europe has agreed to acquire a majority stake in Omnicare, a German pharmaceutical wholesaler specializing in distribution of finished medicines to compounding pharmacies for patient-specific oncology treatments. The seller is a consortium of shareholders that will retain a stake; Omnicare’s management, led by Oliver Tamimi, will remain in place and the deal (terms undisclosed) is expected to close in Q4 2019.
-
Calian Group Acquires Allphase Clinical Research and Alio Health Services
January 31, 2020
Healthcare Services
Calian Group Ltd. announced the acquisition of Ottawa-based Allphase Clinical Research Services Inc. and Alio Health Services Inc., bringing clinical trial management, patient support program capabilities and a proprietary home-care scheduling software into Calian’s Health segment. The deal consideration included $12.0 million in cash, 62,054 common shares and up to $12.0 million of earnouts tied to future EBITDA, with Calian planning to integrate the HOMETM application across its health services to drive new business and efficiencies.
-
Investcorp Acquires Sanos Group
December 14, 2020
Healthcare Services
Investcorp has acquired Sanos Group, a Denmark-based contract research organization (CRO) specialized in osteoarthritis clinical trials and site management. Investcorp said it will support Sanos' international expansion and growth into additional therapeutic areas and geographies, including expanding its research clinic network.
-
Sofia Développement Invests in Comptasanté
March 9, 2022
Accounting & Tax
Sofia Développement has invested in Comptasanté, an online accounting services provider focused on independent healthcare professionals. The deal brings Comptasanté into the Sofia group to create commercial and operational synergies, with Comptasanté management remaining invested and the combined group operating from shared offices in Nantes.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.